Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The regulation of the p53-mediated stress response by MDM2 and MDM4 Perry MECold Spring Harb Perspect Biol 2010[Jan]; 2 (1): a000968Exquisite control of the activity of p53 is necessary for mammalian survival. Too much p53 is lethal, whereas too little permits tumorigenesis. MDM2 and MDM4 are structurally related proteins critical for the control of p53 activity during development, homeostasis, and the response to stress. These two essential proteins regulate both the activation of p53 in response to stress and the recovery of cells following resolution of the damage, yet both are oncogenic when overexpressed. Thus, multiple regulatory circuits ensure that their activities are fine-tuned to promote tumor-free survival. Numerous diverse stressors activate p53, and much research has gone into trying to find commonalities between them that would explain the mechanism by which p53 becomes active. It is now clear that although these diverse stressors activate p53 by different biochemical pathways, one common feature is the effort they direct, through a variety of means, toward disrupting the functions of both MDM2 and MDM4. This article provides an overview of the relationship between MDM2 and MDM4, features the various biochemical mechanisms by which p53 is activated through inhibition of their functions, and proposes some emerging areas for investigation of the p53-mediated stress response.|*Gene Expression Regulation[MESH]|*Genes, p53[MESH]|Animals[MESH]|Apoptosis[MESH]|Cell Cycle Proteins[MESH]|Cell Nucleus/metabolism[MESH]|Gene Expression Regulation, Neoplastic[MESH]|Humans[MESH]|Models, Biological[MESH]|Nuclear Proteins/*metabolism[MESH]|Proto-Oncogene Proteins c-mdm2/*metabolism[MESH]|Proto-Oncogene Proteins/*metabolism[MESH]|Ribosomes/metabolism[MESH]|Tumor Suppressor Protein p53/*metabolism[MESH]|Ultraviolet Rays[MESH] |
